Institut Claudius Regaud

This phase 3 trial tested two types of radiation therapy for glioblastoma, a fast-growing brain tumor. One group received standard 3D radiation, while the other got a more precise intensity-modulated radiation guided by MRI scans. Both groups also took the chemotherapy drug temoz…

This study tested the drug pazopanib in frail elderly patients (75 and older) with metastatic cancer that could not be cured. The goal was to find the safest dose and understand side effects. The trial was terminated early after enrolling 18 patients.